Evidence review
Nano-hydroxyapatite: reading the trials
Hydroxyapatite is the mineral your teeth are actually made of, so putting it in toothpaste is an appealing idea. The research behind it is genuinely promising, and a lot less settled than the packaging suggests.28
What it is meant to do
Enamel is almost entirely mineral, and that mineral is hydroxyapatite. The idea is to put the same material back on the tooth.
Two claims get made and they are usually mixed together. One is that the particles fill small surface defects, leaving mineral to rebuild with. The other is that they plug the open tubes in exposed roots, which is how it helps sensitive teeth. Blocking tubes is easy to show. Preventing cavities is far harder.1
What the research found
Several recent reviews have pooled the trials. They report that it does help prevent cavities, and that it is the best supported fluoride-free ingredient so far. That is a real body of work and should not be waved away.23
The catch in "as good as fluoride"
Most of that case rests on a non-inferiority trial, which does not mean what people think. It does not test whether two treatments are the same. It tests whether the new one is worse than the old by more than an amount the researchers chose in advance. Set that allowance generously and passing gets easy. A study too small to detect a difference can also look like a pass.6
Who paid for it
Industry funding is common in toothpaste research, including work on ingredients we use or discuss elsewhere. Funding and author affiliations matter when judging a review, even when they are properly disclosed.
A systematic review can test whether a set of trials supports a claim. Its methods, included studies and authors' interests all need scrutiny; the label “systematic review” does not make it independent.
In the hydroxyapatite literature, employees of a toothpaste manufacturer are co-authors on the reviews themselves. Two scientists from the research department of the German company behind a leading hydroxyapatite brand are named authors on the main systematic reviews of whether it prevents cavities.29
Those affiliations are disclosed and do not make the findings wrong. They do make independent replication and reviews without those ties especially useful before treating non-inferiority findings as settled.
Fluoride toothpaste has a larger and longer-running evidence base. The difference in study volume and certainty matters more than a simple count of positive trials.13
Your saliva already does this
Hydroxyapatite toothpaste aims to support enamel remineralization. Saliva already supplies calcium and phosphate for that process, especially between acid challenges.1
Saliva can help repair early mineral loss when conditions in the mouth allow it. That natural process does not restore a cavitated tooth. See saliva and oral health.1
Whether adding hydroxyapatite provides a clinically meaningful benefit beyond saliva and other routine care depends on the product and outcome studied. The existing trials do not directly answer every version of that question.2
Dry mouth raises cavity risk and changes the conditions in which any toothpaste works. A brief application cannot replace saliva's continuous flow and buffering. How much hydroxyapatite toothpaste helps people with substantial dry mouth needs direct clinical evidence; the chemistry alone cannot answer that question. See our saliva review for the dry-mouth evidence.
Why mineral purity deserves a test
Trace lead gets into toothpaste through mined mineral ingredients, and hydroxyapatite is one. That general problem is covered in heavy metals testing. There is a reason to look harder at this one.
Hydroxyapatite is used industrially to pull lead out of contaminated water. It works because lead slots into the crystal structure in place of calcium, the two being close enough in size and charge to swap.1112
The same chemistry that makes it good at capturing lead makes it good at keeping any lead that was in the raw material. Once lead sits in that lattice it forms one of the most stable minerals in the family.12
Two qualifications matter. Lead held in a stable mineral may be less available for absorption; total lead and absorbed dose are not the same measurement. And this chemistry does not tell us how much lead, if any, is in a particular toothpaste. That requires a test of the finished product. We have published results for Essential Mint lot 001; they do not describe other formulas or future lots.
The name is not a standard
There is no single material called nano-hydroxyapatite. Products vary in particle size, shape and concentration, so a result from one version does not automatically apply to another tube with the same words on it.1
How to read a hydroxyapatite claim
- "Non-inferior to fluoride" is not the same statement as "as good as fluoride".
- Sensitivity claims stand on firmer ground than cavity claims.
- Check who funded the study being quoted. It is printed in the paper.
- Ask for a finished-product heavy-metals result with a clear sample, date and detection limit. The mineral's chemistry alone cannot tell you the result.
- Your saliva is already delivering this mineral continuously.
Read the full evidence review What the meta-analyses found, what non-inferiority does not prove, and who paid for the trials.
Hydroxyapatite is the mineral teeth are made of, which makes putting it in toothpaste an appealing idea and a heavily marketed one. The research base has grown quickly and now includes several meta-analyses. This article is about what those analyses actually found, which is more encouraging than skeptics allow and considerably less settled than the packaging suggests.
Key points
- Hydroxyapatite is the calcium phosphate that makes up the bulk of enamel, so the proposed mechanism is deposition of the same mineral the tooth is losing.
- Recent systematic reviews and meta-analyses report caries-preventive effects and support non-inferiority to fluoride in the trials conducted so far.
- Non-inferiority is a weaker claim than it sounds. It establishes that a difference larger than a pre-specified margin was not detected, not that the two are equivalent.
- A large share of the trial literature comes from a small number of groups with commercial ties to hydroxyapatite manufacturers, and independent replication remains limited.
- "Nano-hydroxyapatite" is not a standardized material. Particle size, morphology and concentration vary widely between products carrying the same name.
What the material is
Enamel is about 96 percent mineral by weight, and that mineral is a carbonated, calcium deficient hydroxyapatite rather than the pure stoichiometric form. Synthetic hydroxyapatite used in oral care is manufactured in a range of particle sizes and morphologies, with "nano" denoting particles in the nanometer range, typically similar in scale to the crystallites in enamel itself.1
Two mechanisms are usually proposed. The first is deposition: particles adsorb to the enamel surface and to the acquired pellicle, filling surface defects and providing a mineral reservoir that can be incorporated during remineralization. The second is occlusion: particles physically plug exposed dentinal tubules, which is the basis of hydroxyapatite's use for sensitivity.
These are genuinely different claims requiring different evidence, and conflating them is the most common error in consumer coverage. Tubule occlusion for sensitivity is a comparatively easy effect to demonstrate. Preventing caries is a much harder claim.
What the meta-analyses found
An updated systematic review and meta-analysis of clinical evidence for caries prevention by hydroxyapatite concluded that the available trials support a caries-preventive effect.2 A separate systematic review and meta-analysis focused specifically on hydroxyapatite-based fluoride-free toothpastes and their role in preventing and remineralizing initial caries lesions reached broadly supportive conclusions.3
Individual randomized trials add texture. A triple-blind randomized clinical trial examined hydroxyapatite-fluoride toothpastes and caries activity,4 and a further randomized trial assessed hydroxyapatite-containing toothpastes against caries-related variables.5 An earlier trial in children compared a hydroxyapatite toothpaste with a fluoride toothpaste for caries prevention and remineralization.6 A broader systematic review of fluoride-free toothpastes assessed hydroxyapatite alongside other active ingredients and found it the best supported of them.7
That is a real and growing body of work, and it is more than most alternative actives can claim. It should not be dismissed.
What non-inferiority does and does not establish
Much of the hydroxyapatite case rests on non-inferiority trials against fluoride, and this design is widely misreported. A non-inferiority trial does not test whether two treatments are the same. It tests whether the new treatment is worse than the comparator by more than a margin chosen in advance by the investigators.
Three consequences follow. The conclusion depends heavily on how wide that margin was set, and a generous margin makes non-inferiority easier to demonstrate. A failure to detect a difference in an underpowered trial can look like non-inferiority when it is really uninformative. And non-inferiority to fluoride is only as meaningful as the fluoride arm's own performance in that particular trial.
A commentary in Evidence-Based Dentistry asked directly whether there is yet enough evidence to recommend hydroxyapatite toothpaste for preventing dental caries, and was considerably more cautious than the meta-analyses it examined.8 Anyone forming a view on this ingredient should read the skeptical appraisal alongside the supportive ones.
Who funded the research
Manufacturer funding is the norm in dentifrice research. We say so on our baking soda and stannous fluoride pages, and it would be selective to raise it here and nowhere else. The hydroxyapatite literature is distinctive for a different reason, and it concerns where in the evidence hierarchy the commercial interest sits.
The usual structure has a separation of function. Manufacturers fund primary trials, and systematic reviews and meta-analyses are then conducted by independent groups who pool, appraise and adjudicate those trials. The review is the corrective. It is the reason a pooled estimate is treated as stronger evidence than any single sponsored study.
In the hydroxyapatite literature that separation is largely absent at the review level. Two senior scientists in the research department of Dr. Kurt Wolff GmbH & Co. KG, the German manufacturer behind a leading hydroxyapatite dentifrice brand, appear as named co-authors on the principal systematic reviews and meta-analyses of hydroxyapatite for caries prevention, including the 2021 review and the 2024 updated review this article relies on.9 Company-affiliated reviews of hydroxyapatite formulation and of hydroxyapatite in children's oral care carry the same authorship.10
The point is structural rather than personal. These relationships are declared in the papers, which is correct practice and the reason we can describe them at all. Several co-authors are academics without commercial ties. Disclosure is not misconduct and none of this establishes that the findings are wrong. What it does mean is narrower and still important: the independent replication that a reader assumes sits behind a meta-analysis has, in this case, not yet occurred. The volume of publication substantially overstates the number of independent groups behind it.
A commentary in Evidence-Based Dentistry asked directly whether there is enough evidence to recommend hydroxyapatite toothpaste for preventing caries, and was considerably more cautious than the reviews it examined.6 That is the kind of arm's-length appraisal this field is short of, and anyone forming a view should read it alongside the supportive syntheses.
The comparison with fluoride is the instructive one. The fluoride evidence base includes decades of trials funded by governments, national health services and public research bodies with no product to sell, pooled by reviewers with no stake in the outcome. That is why the two literatures do not carry equal weight even where the reported effect sizes look similar. It is a statement about evidentiary independence, not about chemistry, and it is the single most important thing to hold in mind when a tube claims parity with fluoride.
The comparator nobody runs: saliva
A question the hydroxyapatite literature does not confront directly, and which follows from elementary physical chemistry: saliva is already supersaturated with respect to hydroxyapatite. It carries more calcium and phosphate in solution than would be stable in equilibrium with tooth mineral, which means that at neutral pH the thermodynamic gradient already points toward deposition rather than dissolution. Mineral lost from the enamel surface is continuously replaced without any intervention at all. The mechanism is set out in saliva and oral health.
This makes the proposed mechanism of hydroxyapatite dentifrice unusual to evaluate. It proposes to supply the same mineral, in the same mouth, to a fluid that is already saturated with it. Fluoride does something structurally different: it alters the solubility of the mineral being deposited, producing a phase that withstands a lower pH. Adding hydroxyapatite adds more of the ion already present in excess.
Two mechanisms could still make that worthwhile, and both are plausible. Particles adsorbed to enamel and pellicle may act as a physically localized reservoir at the surface, which is not the same as raising bulk salivary concentration. And during an acid episode, when saliva has become undersaturated, an adjacent solid phase may buffer locally. Neither has been isolated in a clinical trial, and the trials that exist compare hydroxyapatite against fluoride or against placebo dentifrice rather than against the salivary baseline itself.
The ordering is worth stating plainly. Salivary function is a far more powerful determinant of whether enamel survives than any remineralizing agent applied for two minutes twice daily, and the same point is made about fluoride in how fluoride works. The asymmetry is sharper here. A person with normal salivary flow already has continuous delivery of exactly the ions hydroxyapatite supplies. A person with significant hyposalivation has lost that delivery, and a twice-daily application is a poor substitute for a supersaturated bath running continuously. The intervention is weakest in the mouths that need it most, which is the opposite of a good therapeutic profile.
The word means several different things
There is no single standardized material called nano-hydroxyapatite. Products differ in particle size distribution, crystal morphology, degree of carbonate substitution, whether the particles are aggregated, and the concentration used in the formulation. All of these plausibly affect adsorption to enamel and incorporation into remineralizing mineral.
The practical consequence is that a trial result obtained with one manufacturer's material does not automatically transfer to another product carrying the same words on the tube. Meta-analyses that pool across heterogeneous materials are useful for detecting whether an effect exists at all and less useful for predicting what any particular product will do.
Where this leaves the evidence
Reasonably supported: hydroxyapatite adsorbs to enamel and pellicle; it occludes dentinal tubules and has a defensible case in dentin hypersensitivity; multiple recent meta-analyses report caries-preventive effects; it is the best evidenced of the fluoride-free actives studied to date.
Not established: equivalence to fluoride, which non-inferiority trials do not demonstrate; long-term caries outcomes, since most trials are short relative to the timescale on which caries develops; which specific material properties matter; and how much of the reported effect survives independent replication. Several reviews also rely partly on in vitro and in situ models standing in for clinical caries endpoints.
Elemental purity, and why apatite is a special case
How trace heavy metals enter oral care products through mined mineral feedstocks, and what independent 2025 testing found across the category, is covered in heavy metals testing and is not repeated here. What follows is specific to apatite, and we have not seen it raised in consumer coverage of this ingredient.
Hydroxyapatite is used industrially as a sorbent for removing lead from contaminated water and soil. That is an established remediation application, and it works because of the crystal chemistry: Pb2+ exchanges rapidly with Ca2+ in the apatite lattice, the two ions being similar enough in charge and radius to substitute.11
The exchange does not stop at simple substitution. Lead uptake proceeds through dissolution of the apatite followed by precipitation of hydroxypyromorphite, Pb10(PO4)6(OH)2, described in the literature as a very stable phase, and it is that stability which makes apatite useful for locking lead out of circulation.12
The implication is straightforward and uncomfortable. A material selected by environmental engineers for its avidity for lead is, by the same property, a material that will preferentially retain any lead present in its feedstock or process water. Affinity does not distinguish between lead you are trying to capture and lead you would rather exclude. This is an argument for scrutiny of supplier purity and for lot-level testing, not an argument that hydroxyapatite dentifrices contain lead, which is a separate empirical question we have not measured.
Two qualifications, both of which cut against the alarming reading and belong here for that reason. First, the same stability may reduce bioavailability. Lead immobilized in a pyromorphite lattice is, by design, poorly soluble, and the toxicological significance of tightly bound versus free lead in an ingested trace quantity is not settled. A high total figure and a high absorbed dose are not the same claim.
Second, this chemistry is not a test result for a finished toothpaste. Mineral raw materials can introduce impurities, but the amount in any formula has to be measured rather than inferred from an ingredient name. Essential Mint does not contain calcium carbonate or hydroxyapatite. We publish the result for our own lot 001, including the lead we did find. That single result says nothing about a competitor's product or future Athena lots.
References
- Meyer F, Amaechi BT, Fabritius HO, Enax J. Overview of calcium phosphates used in biomimetic oral care. Open Dentistry Journal. 2018;12:406-423. PMID 29988215.
- Pawinska M, Paris S, Meyer F, Enax J, et al. Clinical evidence of caries prevention by hydroxyapatite: an updated systematic review and meta-analysis. Journal of Dentistry. 2024;151:105429. PMID 39471896.
- Chatzidimitriou K, et al. The role of hydroxyapatite-based, fluoride-free toothpastes on the prevention and the remineralization of initial caries lesions: a systematic review and meta-analysis. Journal of Dentistry. 2025;156:105691. PMID 40107597.
- Cocco F, Cagetti MG, et al. Hydroxyapatite-fluoride toothpastes on caries activity: a triple-blind randomized clinical trial. International Dental Journal. 2025;75(2):632-642. PMID 39971658.
- Campus G, Cagetti MG, et al. Effects of hydroxyapatite-containing toothpastes on some caries-related variables: a randomised clinical trial. International Dental Journal. 2024;74(4):754-761. PMID 38453554.
- Amaechi BT, AbdulAzees PA, Alshareif DO, et al. Comparative efficacy of a hydroxyapatite and a fluoride toothpaste for prevention and remineralization of dental caries in children. BDJ Open. 2019;5:18. PMID 31839988.
- Unterbrink P, et al. Fluoride-free toothpastes for caries prevention: a systematic review of clinical evidence on active ingredients. Clinical, Cosmetic and Investigational Dentistry. 2026;18:586895. PMID 41948279.
- Gugnani N, Gugnani S. Do we have enough evidence to recommend hydroxyapatite toothpaste for preventing dental caries? Evidence-Based Dentistry. 2025;26(1):38-39. PMID 39984606.
- Limeback H, Enax J, Meyer F. Biomimetic hydroxyapatite and caries prevention: a systematic review and meta-analysis. Canadian Journal of Dental Hygiene. 2021;55(3):148-159. PMC8641555. And Pawinska M, Paszynska E, Amaechi BT, Meyer F, Enax J, Limeback H. Clinical evidence of caries prevention by hydroxyapatite: an updated systematic review and meta-analysis. Journal of Dentistry. 2024. ScienceDirect. Meyer and Enax are identified in both as Research Department, Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany.
- Meyer F, Enax J, et al. Overview on Adjunct Ingredients Used in Hydroxyapatite-Based Oral Care Products. Biomimetics. 2022. PMC9775056. See also Hydroxyapatite as Remineralization Agent for Children's Dental Care. Frontiers in Dental Medicine. 2022;3:859560. Frontiers.
- A theoretical and experimental study of lead substitution in calcium hydroxyapatite. Northwestern. See also Nano-hydroxyapatite and its composites for heavy metal removal from water: a comprehensive review. ScienceDirect.
- In vitro and in vivo studies of lead immobilization by synthetic hydroxyapatite. Environmental Pollution. 2003;122(3):405-410. ScienceDirect.
- Marinho VCC, Higgins JPT, Sheiham A, Logan S. Fluoride toothpastes for preventing dental caries in children and adolescents. Cochrane Database of Systematic Reviews. 2003;(1):CD002278. PMID 12535435.
This article is educational and reviews published research on hydroxyapatite as an ingredient class. It is not medical or dental advice, not a diagnosis, and not a claim about any product. Our own toothpaste does not contain hydroxyapatite. If you have a specific concern about your teeth or gums, ask a dentist.
Keep reading
Athena Naturals
Seven ingredients. Fluoride-free, no water, no preservatives, no surfactants. Made in small batches in Seattle.